129 related articles for article (PubMed ID: 2473086)
1. Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines.
Broers JL; Rot MK; Oostendorp T; Bepler G; De Leij L; Carney DN; Vooijs GP; Ramaekers FC
J Cell Sci; 1988 Sep; 91 ( Pt 1)():91-108. PubMed ID: 2473086
[TBL] [Abstract][Full Text] [Related]
2. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies.
Broers JL; Carney DN; Klein Rot M; Schaart G; Lane EB; Vooijs GP; Ramaekers FC
J Cell Sci; 1986 Jul; 83():37-60. PubMed ID: 2433295
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.
Broers JL; Carney DN; de Ley L; Vooijs GP; Ramaekers FC
Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4409-13. PubMed ID: 2409557
[TBL] [Abstract][Full Text] [Related]
4. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
5. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors.
Leoncini P; Bellizzi de Marco E; Bugnoli M; Mencarelli C; Vindigni C; Cintorino M
Pathol Res Pract; 1989 Dec; 185(6):848-55. PubMed ID: 2482482
[TBL] [Abstract][Full Text] [Related]
6. Compensation of type I and type II cytokeratin pools in lung cancer.
Kanaji N; Bandoh S; Fujita J; Ishii T; Ishida T; Kubo A
Lung Cancer; 2007 Mar; 55(3):295-302. PubMed ID: 17161499
[TBL] [Abstract][Full Text] [Related]
7. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.
de Leij L; Postmus PE; Buys CH; Elema JD; Ramaekers F; Poppema S; Brouwer M; van der Veen AY; Mesander G; The TH
Cancer Res; 1985 Dec; 45(12 Pt 1):6024-33. PubMed ID: 2998591
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
Broers JL; Ramaekers FC; Rot MK; Oostendorp T; Huysmans A; van Muijen GN; Wagenaar SS; Vooijs GP
Cancer Res; 1988 Jun; 48(11):3221-9. PubMed ID: 2452687
[TBL] [Abstract][Full Text] [Related]
9. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
10. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
11. Molecular diversity of cytokeratins: significance for cell and tumor differentiation.
Moll R
Acta Histochem Suppl; 1991; 41():117-27. PubMed ID: 1725827
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratins negatively regulate the invasive potential of lung cancer cell lines.
Kanaji N; Bandoh S; Ishii T; Fujita J; Ishida T; Matsunaga T; Kubo A
Oncol Rep; 2011 Oct; 26(4):763-8. PubMed ID: 21701782
[TBL] [Abstract][Full Text] [Related]
13. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin and neurofilament in lung carcinomas.
van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
[TBL] [Abstract][Full Text] [Related]
15. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
Walker C; Wright-Perkins S
Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994
[TBL] [Abstract][Full Text] [Related]
16. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer.
Takakuwa O; Maeno K; Kunii E; Ozasa H; Hijikata H; Uemura T; Kasai D; Ohkubo H; Miyazaki M; Oguri T; Niimi A
Lung Cancer; 2013 Aug; 81(2):174-9. PubMed ID: 23706418
[TBL] [Abstract][Full Text] [Related]
17. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
18. An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.
Doyle LA; Borges M; Hussain A; Elias A; Tomiyasu T
J Clin Invest; 1990 Dec; 86(6):1848-54. PubMed ID: 1701450
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
20. Expression of intermediate filaments in normal and neoplastic exocrine pancreas.
Santini D; Ceccarelli C; Martinelli GN; Pasquinelli G; Leone O; Marrano D; Mancini AM
Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
